One consistency is that many studies have shown that NLRX1 attenuates diseases, including chronic obstructive pulmonary disease (COPD) [135], autoimmune diseases [136–139], and cancer [140–144]. Here, NLRX1 is linked to chronic obstructive pulmonary disease.